During the past decade, CHU Nancy conducted 421 clinical trials. In the 10-year time frame, 421 clinical trials started and 41 clinical trials were completed, i.e. on average, 9.7% percent of trials that started reached the finish line to date. In the past 5 years, 213 clinical trials started and 28 clinical trials were completed. i.e. 13.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CHU Nancy" #1 sponsor was "Central Hospital, Nancy, France" with 161 trials, followed by "University Hospital, Bordeaux" with 16 trials sponsored, "Centre Hospitalier Universitaire de Saint Etienne" with 15 trials sponsored, "Nantes University Hospital" with 15 trials sponsored and "University Hospital, Brest" with 15 trials sponsored. Other sponsors include 351 different institutions and companies that sponsored additional 169 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CHU Nancy" #1 collaborator was "Ministry of Health, France" with 18 trials as a collaborator, "Institut National de la Santé Et de la Recherche Médicale, France" with 14 trials as a collaborator, "Central Hospital, Nancy, France" with 8 trials as a collaborator, "National Cancer Institute, France" with 6 trials as a collaborator and "University Hospital, Lille" with 6 trials as a collaborator. Other collaborators include 291 different institutions and companies that were collaborators in the rest 254 trials.

According to Clinical.Site data, the most researched conditions in "CHU Nancy" are "Multiple Sclerosis" (14 trials), "Ulcerative Colitis" (14 trials), "Multiple Myeloma" (13 trials), "Atrial Fibrillation" (8 trials) and "Crohn Disease" (8 trials). Many other conditions were trialed in "CHU Nancy" in a lesser frequency.

Most popular intervention types in "CHU Nancy" are "Drug" (196 trials), "Other" (148 trials), "Device" (73 trials), "Procedure" (71 trials) and "Biological" (27 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (43 trials), "Ocrelizumab" (7 trials), "MRI" (6 trials), "Dexamethasone" (5 trials) and "Gemcitabine" (5 trials). Other intervention names were less common.

The vast majority of trials in "CHU Nancy" are 538 trials for "All" genders, 27 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are 203 active trials in "CHU Nancy". 10 are not yet recruiting, 146 are recruiting, 43 are Active, not recruiting, and 4 are Enrolling by invitation. In total, there were 270 completed trials in CHU Nancy, 2 suspended trials, and 34 terminated clinical trials to date.

Out of the total trials that were conducted in CHU Nancy, 7 "Phase 1" clinical trials were conducted, 82 "Phase 2" clinical trials and 116 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 24 trials, and there were also 155 trials that are defined as “Not Applicable".

CHU Nancy has several departments that took part in Clinical trials: "Nuclear medicine department CHRU de NANCY" - 2 trials